Table 1.
Comparison of baseline characteristics between hypothermic and normothermic surgery group.
| Normothermic group (n = 98) |
Hypothermic group (n = 95) |
|
|---|---|---|
| Age (years) † | 66.3 ± 6.2 | 64.7 ± 7.6 |
| HTN (n, %) | 41 (42) | 43 (45) |
| DM (n, %) | 16 (16) | 17 (18) |
| BMI (kg/m2) † | 24.5 ± 3.0 | 24.6 ± 2.7 |
| Charlson Comorbidity Index (CCI) (n, %) | ||
| CCI 0 | 61 (62.2) | 60 (63.2) |
| CCI 1 | 27 (27.6) | 27 (28.4) |
| CCI 2–3 | 10 (10.2) | 8 (8.4) |
| Pre-operative PSA (ng/dL) † | 7.2 ± 4.7 | 7.5 ± 3.2 |
| Prostate volume (mL) † | 38.0 ± 13.1 | 34.7 ± 14.6 |
| Period between prostate biopsy and operation (days) † | 61.1 ± 39.5 | 59.7 ± 53.5 |
| MRI T stage (n, %) | ||
| T0-T2 | 83 (95) | 90 (96) |
| T3 | 5 (5) | 4 (4) |
| ISUP GG (n, %) | ||
| ISUP GG 1–2 | 68 (69) | 75 (79) |
| ISUP GG 3–5 | 30 (31) | 20 (21) |
| Total IIEF score† | 11.2 ± 7.6 | 11.6 ± 7.4 |
| EPIC-CP score† | ||
| Urinary incontinence | 1.35 ± 1.48 | 1.14 ± 1.43 |
| Urinary subscale | 2.42 ± 2.88 | 2.60 ± 2.84 |
| Bowel subscale | 1.18 ± 2.45 | 1.39 ± 2.73 |
| Sexual subscale | 4.87 ± 2.28 | 4.73 ± 2.49 |
| Hormonal subscale | 0.86 ± 1.90 | 1.29 ± 2.62 |
| Total score | 10.7 ± 7.35 | 11.2 ± 8.20 |
| EQ-5D-5 L VAS score† | 82.0 ± 12.8 | 80.2 ± 13.3 |
| EQ-5D-5 L utility score† | 0.93 ± 0.09 | 0.93 ± 0.09 |
PSA: prostate-specific antigen, ISUP: international society of urological pathologists, GG: grade group, VAS: visual analoque scale †Values are mean ± SD.